Ragwitek (short ragweed pollen allergen extract sublingual tablets – ALK-Abello) — Cigna
Short ragweed pollen-induced allergic rhinitis with or without conjunctivitis
Initial criteria
- Patient is age ≥ 5 years; AND
- Ragwitek therapy is initiated 12 weeks prior to the expected onset of the short ragweed pollen season; AND
- Diagnosis of short ragweed pollen-induced allergic rhinitis is confirmed by ONE of the following (i or ii):
- i. Patient has a positive skin test response to short ragweed pollen; OR
- ii. Patient has a positive in vitro test (a blood test) for allergen-specific immunoglobulin E antibodies for short ragweed pollen.
Approval duration
1 year